What Does TTABV Biotherapeutics Do?

Total employees320
HeadquartersCambridge
Founded2016

TTABV Biotherapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of transformative therapies for patients suffering from severe diseases with limited treatment options, primarily in oncology and immunology. Leveraging our proprietary [e.g., MultiModal Antibody Therapeutics™] platform, we aim to engineer next-generation medicines that can address complex biological targets. Our team of world-class scientists and clinicians is driven by a sense of urgency and a deep commitment to improving human health. We are focused on advancing our robust pipeline of innovative drug candidates through rigorous clinical development and towards market approval.

Where Is TTABV Biotherapeutics's Headquarters?

TTABV Biotherapeutics officeTTABV Biotherapeutics officeTTABV Biotherapeutics officeTTABV Biotherapeutics office
*Images sourced via web search. Rights belong to original owners

HQ Function

The headquarters serves as the primary center for research and development, corporate strategy, business development, and global administrative operations.

Notable Features:

Features state-of-the-art laboratory spaces, advanced research equipment, collaborative open-plan offices, and sustainable building design elements.

Work Culture:

TTABV fosters a dynamic, inclusive, and science-driven work culture. Emphasis is placed on collaboration, innovation, continuous learning, and a shared mission to impact patient lives. Employees experience a fast-paced environment with opportunities for significant professional growth.

HQ Significance:

Its Cambridge location provides unparalleled access to a rich ecosystem of academic institutions (like MIT and Harvard), research hospitals, venture capital, and a dense talent pool of experienced biotech professionals.

Values Reflected in HQ: The headquarters' design and functionality reflect TTABV's core values of innovation, scientific excellence, collaboration, and patient-centricity.

Location:

TTABV Biotherapeutics operates with a global mindset, conducting clinical trials across North America, Europe, and select sites in Asia-Pacific. Our research collaborations and strategic partnerships span multiple continents, enabling us to access diverse scientific expertise and patient populations to advance our therapeutic programs worldwide.

Street Address:

75 Binney Street

City:

Cambridge

State/Province:

Massachusetts

Country:

USA

Where Else Does TTABV Biotherapeutics Operate Around the World?

South San Francisco, California/USA

Address: 400 Oyster Point Blvd, Suite 250, South San Francisco, CA 94080

To manage and expand clinical trial activities in the Western US, foster relationships with West Coast research institutions and partners, and recruit specialized talent.

Zug, Switzerland

Address: Gubelstrasse 11, 6300 Zug, Switzerland

To navigate European regulatory pathways, coordinate multi-national clinical trials within Europe, and prepare for potential market entry and commercialization in key European markets.

Buying Intent Signals for TTABV Biotherapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading TTABV Biotherapeutics? Meet the Executive Team

As of April 2025, TTABV Biotherapeutics' leadership includes:

Dr. Eleanor Vance - President & Chief Executive Officer
Dr. Samuel Griggs - Chief Scientific Officer & Head of R&D
Anita Chen - Chief Financial Officer
Dr. Ben Carter - Chief Medical Officer
Laura Hopkins - Chief Operating Officer

Who's Investing in TTABV Biotherapeutics?

TTABV Biotherapeutics has been backed by several prominent investors over the years, including:

Longitude Venture Partners
OrbiMed Advisors
Flagship Pioneering
ARCH Venture Partners
RA Capital Management

What Leadership Changes Has TTABV Biotherapeutics Seen Recently?

Hire1
Exits1

In the past year, TTABV Biotherapeutics has strategically expanded its executive leadership by appointing a new Chief Commercial Officer to prepare for potential product launches and has seen a planned transition in the Head of Regulatory Affairs.

Departures

Dr. Susan Miller, Dr. Susan Miller retired after a distinguished career, significantly contributing to TTABV's regulatory strategy. Search for her successor is ongoing.

New Appointments:

Michael Davies, Michael Davies was appointed as Chief Commercial Officer to build out TTABV's commercial capabilities and strategy for its late-stage assets.

What Technology (Tech Stack) Is Used byTTABV Biotherapeutics?

Discover the tools TTABV Biotherapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

TTABV Biotherapeutics Email Formats and Examples

TTABV Biotherapeutics typically uses a standard email format combining the first initial with the full last name of the employee, followed by the company domain.

f[last]@ttabvbiotherapeutics.com (e.g., evance@ttabvbiotherapeutics.com)

Format

sgriggs@ttabvbiotherapeutics.com

Example

90%

Success rate

What's the Latest News About TTABV Biotherapeutics?

BioWorldMay 10, 2024

TTABV Biotherapeutics Presents Positive Phase 2b Data for TTB-101 in Lupus Nephritis at EULAR 2024

TTABV Biotherapeutics announced compelling results from its Phase 2b study of TTB-101, an investigational therapy for lupus nephritis. The data, presented at the European Congress of Rheumatology (EULAR), showed statistically significant improvements in renal response rates and key secondary endpoints....more

Endpoints NewsFebruary 20, 2024

TTABV Biotherapeutics Secures $150M in Series C Financing to Advance Oncology Pipeline and Prepare for Pivotal Trials

TTABV Biotherapeutics successfully closed a $150 million Series C financing round. The funding will be used to advance its lead oncology candidate, TTB-205, into pivotal Phase 3 trials and progress its earlier-stage pipeline of novel immunotherapies....more

Company Press ReleaseNovember 06, 2023

TTABV Biotherapeutics Highlights Novel Mechanism of Action for TTB-205 at SITC Annual Meeting

At the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting, TTABV Biotherapeutics presented preclinical data elucidating the unique mechanism of action of TTB-205, its lead immuno-oncology candidate. The findings demonstrate potent tumor cell killing and immune activation....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including TTABV Biotherapeutics, are just a search away.